Full Press Release Details
JANUARY 2022 CORPORATE PRESENTATION SLIDES
GERN
JANUARY 2022
Key Takeaway: JANUARY 2022 CORPORATE PRESENTATION SLIDES
Price reaction · baseline $1.17 (2022-01-07 close) · clean, no other GERN news in the window
day 0 close
+0.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+48%
120-day peak, hindsight
Typical move
4.4%
average across 4 past catalysts
Cash runway
~66 mo
Minimal dilution risk
Lead asset
Imetelstat
Phase 3 · Myelofibrosis